MAP4K1 and neoplasm: Studies indicate that HPK1-knockout or kinase-dead mice showed improved anti-tumor responses, evidenced by heightened T-cell activation and proliferation, increased levels of IL-2, resistance to immunosuppressive factors (like PGE2), and better control of tumors [21,22,23,24,25,26].